# FDA Inspection 637957 - Summa Western Reserve Hospital LLC - January 08, 2010

Source: https://www.keypedia.com/records/fda_inspections/summa-western-reserve-hospital-llc/9fce5262-2c52-4ea1-a028-16b2dd9d3fcc
Source feed: FDA_Inspections

> FDA Inspection 637957 for Summa Western Reserve Hospital LLC on January 08, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 637957
- Company Name: Summa Western Reserve Hospital LLC
- Inspection Date: 2010-01-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 859419 - 2013-12-17](https://www.keypedia.com/records/fda_inspections/summa-western-reserve-hospital-llc/cd1887b4-23c0-4288-b667-94b0095b19ee)
- [FDA Inspection 752116 - 2011-11-02](https://www.keypedia.com/records/fda_inspections/summa-western-reserve-hospital-llc/2fe7056e-3056-4655-ac31-67a759ce81bb)

Company: https://www.keypedia.com/companies/summa-western-reserve-hospital-llc/2f845779-d634-4e2b-b4be-134700eaa5e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d